PND98 - DETERMINING THE VALUE OF OCREVUS® (OCRELIZUMAB) FOR THE TREATMENT OF MULTIPLE SCLEROSIS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)
Abstract
Authors
C Alerany R Fernández L Landete A Rodríguez S Sandoval M Valdivia A Gil